Impact of anti-vaccine movements on pertussis control: The untold story

Lancet

Volumn 351, Issue 9099, 1998, Pages 356-361

  Gangarosa, E J ^a,e   Galazka, A M ^b   Wolfe, C R ^c   Phillips, L M ^c   Gangarosa, R E ^e   Miller, E ^d   Chen, R T ^c  

^a EMORY UNIVERSITY   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE;

AUSTRALIA; DRUG EFFICACY; GERMAN DEMOCRATIC REPUBLIC; GERMAN FEDERAL REPUBLIC; HUMAN; HUNGARY; INCIDENCE; IRELAND; ITALY; JAPAN; MORBIDITY; PERTUSSIS; POLAND; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RUSSIAN FEDERATION; SWEDEN; UNITED KINGDOM; UNITED STATES;

EID: 0032583917     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)04334-1     Document Type: Review

References (42)

1. 1 Galazka A. Control of pertussis in the world. World Health Stat Q 1992; 45: 238-47.
2. 2 Ström J. Is universal vaccination against pertussis always justified? BMJ 1960; 2: 1184-86.
3. 3 Stewart GT. Vaccination against whooping-cough. Lancet 1977; i: 234-37.
4. 4 Chen RT, Rastogi SC, Mullen JR, et al. The vaccine adverse event reporting system (VAERS). Vaccine 1994; 12: 542-50.
5. 5 Sutter RW, Cochi SL. Pertussis hospitalizations and mortality in the United States, 1985-1988: evaluation of the completeness of national reporting. JAMA 1992; 267: 386-91.
6. 6 Joo I. Epidemiology of pertussis in Hungary. In: Symposium on pertussis: valuation and research on acellular pertussis vaccines. Dev Biol Stand 1991; 73: 357-59.
7. 7 Finger H, Wirsing von Konig CH, Tacken A, and Wassilak SG. The epidemiological situation of pertussis in the Federal Republic of Germany. In: Symposium on pertussis: evaluation and research on acellular pertussis vaccines. Dev Biol Stand 1991; 73: 343-55.
8. 8 Coulter HL, Fisher BL. DTP: a shot in the dark: why the P in the DTP vaccination may be hazardous to your child's health. New York, Garden City Park: Avery Publishing Group Inc, 1991.
9. 9 Centers for Disease Control and Prevention. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children: recommendations of the Advisory Committee on Immunization Practices. MMWR CDC Surveill Sum 1997; 46 (RR-7): 1-25.
10. 10 Onorato IM, Wassilak SG, Mead B. Efficacy of whole-cell pertussis vaccine in preschool children in the United States. JAMA 1992; 267: 2745-49.
11. 11 Evans G. Vaccine liability and safety: a progress report. Pediatric Infect Dis J 1996; 15:477-78.
12. 12 Romanus V, Jonsell R, Bergquist S. Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr Infect Dis J 1987; 6: 364-71.
13. 13 Kimura M, Kuno-Sakai H. Developments in pertussis immunisation in Japan. Lancet 1990; 336: 30-32.
14. 14 Kanai K. Japan's experience in pertussis epidemiology and vaccination in the past thirty years. Jpn J Med Sci Biol 1980; 33: 107-43.
15. 15 Kimura M, Kuno-Sakai H. Immunization system in Japan. Acta Paediatr Jpn 1988; 30: 109-26.
16. 16 Kulenkampff M, Schwartzman JS, Wilson J. Neurological complications of pertussis inoculation. Arch Dis Child 1974; 49: 46-49.
17. 17 Malleson PN, Bennett JC. Whooping-cough admissions to a paediatric hospital over 10 years: the protective value of immunisation. Lancet 1977; i: 237-39.
18. 18 PHLS epidemiological research laboratory. Efficacy of pertussis vaccination in England. BMJ 1982; 285: 357-59.
19. 19 Salisbury D. The immunization program in England: 25th National Immunization Conference Proceedings 1991, Centers for Disease Control and Prevention, Atlanta, GA, 1992: 49-52.
20. 20 Velimirovic B. Hostility to immunization, presented at the WHO Meeting of National Programme Managers, St. Vincent/Val d'Aosta. Copenhagen: World Health Organization/Expanded Programme on Immunizations/European Regional Office, 1991.
21. 21 Howell F, Jennings S. The epidemiology of pertussis in the Republic of Ireland. Commun Dis Rep CDR Rev 1992; 2: R31-33.
22. 22 Binkin NJ, Salmaso S, Tozzi AE, Scuderi G. Epidemiology of pertussis in a developed country with low vaccination coverage: Italian experience. Pediatr Infect Dis J 1992; 11: 653-61.
23. 23 Stroffolini T, Giammanco A, De Crescenzo L, et al. Prevalence of pertussis IgG antibodies in children in Palermo, Italy. Infection 1989; 17: 280-83.
24. 24 McIntyre CR, Nolan T. Attitudes of Victorian vaccine providers to pertussis vaccine. Med J Austr 1994; 161: 295-99.
25. 25 Lester R, Nolan T. DT vaccine in place of DTP vaccine for children (editorial). Med J Austr 1993; 159: 631.
26. 26 Scheibner V. Vaccination: 100 years of orthodox research shows that vaccines represent a medical assault on the immune system. Santa Fe, NM: New Atlantean Press, 1996.
27. 27 Plotkin SA, Cadoz M. The acellular pertussis vaccine trials: an interpretation. Pediatr Infect Dis J 1997;16: 508-17.
28. 28 Halperin SA, Bortolussi R, MacLean D, Chisholm N. Persistence of pertussis in an immunized population: results of the Nova Scotia enhanced pertussis surveillance program. J Pediatr 1989; 115: 686-93.
29. 29 Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996; 334: 341-48.
30. 30 Hill AB. The environment and disease: association or causation?: the President's address. Proc R Soc Med 1965; 58: 295-300.
31. 31 Fine PEM, Clarkson JA. Individual versus public priorities in the determination of optimal vaccination policies. Am J Epidemiol 1986; 124: 1012-20.
32. 32 Hardin G. The tragedy of the commons. Science 1968; 162: 1243-48.
33. 33 Freed GL, Katz SL, Clark SJ. Safety of vaccinations: Miss America, the media, and public health. JAMA 1996; 276: 1869-1918.
34. 34 Mendelsohn R. Immunizations: the terrible risks your children face that your doctor won't reveal. Evanston, IL: The Peoples Doctor Inc, 1988.
35. 35 Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Epidemiol Rev 1988; 10: 212-41.
36. 36 Committee on Infectious Diseases (the Red Book Committee). The relationship between pertussis vaccine and central nervous system sequelae: continuing assessment. Pediatrics 1996; 97: 279-81.
37. 37 Centers for Disease Control and Prevention. Update: vaccine side effects, adverse reactions, contraindications, and precautions after DTP vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR CDC Surveill Summ 1996; 45: 22-35.
38. 38 Griffith AH. Permanent brain damage and pertussis vaccination: is the end of the saga in sight? Vaccine 1989; 7: 199-210.
39. 39 Miller E. Pertussis vaccine trials: public health implications: United Kingdom. Dev Biol Stand 1996; 89: 301-02.
40. 40 Taylor CE, Cutts F, Taylor ME. Ethical dilemmas in current planning for polio eradication. Am J Public Health 1997; 87: 922-25.
41. 41 Nicholl A, Gardner A. Whooping cough and unrecognized postperinatal mortality. Arch Dis Child 1988; 63: 41-47.
42. 42 Lindgren C, Milerad J, Lagercrantz H. Sudden infant death and prevalence of whooping cough in the Swedish and Norwegian communities. Eur J Paediatr 1997; 156: 405-09.